Form 8-K - Current report:
SEC Accession No. 0001193125-25-300538
Filing Date
2025-11-26
Accepted
2025-11-26 16:15:12
Documents
12
Period of Report
2025-11-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d41366d8k.htm   iXBRL 8-K 27115
  Complete submission text file 0001193125-25-300538.txt   142249

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tcrx-20251125.xsd EX-101.SCH 2844
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcrx-20251125_lab.xml EX-101.LAB 17978
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcrx-20251125_pre.xml EX-101.PRE 11254
14 EXTRACTED XBRL INSTANCE DOCUMENT d41366d8k_htm.xml XML 3637
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

EIN.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40603 | Film No.: 251530428
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)